TrialAntiviral therapy2018

Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s.

Charles S Venuto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.